Background: Finding opportunities for improving efficiency is important, given the pressure on national health budgets. Identifying and reducing low-value interventions that deliver little benefit is key. A systematic literature evaluation was done to identify low-value interventions in general surgery, with further assessment of their cost.
Introduction
An expected £30 billion (€34 billion; exchange rate 28 September 2017) funding gap is expected by 2020-2021 in the English National Health Service (NHS) 1 . This provides motivation to identify and reduce the use of healthcare interventions that deliver little benefit, and which could be substituted with less costly alternatives without affecting safety and quality of care. The goal is not to implement cost-cutting strategies, but rather to improve value (health outcomes achieved per monetary unit spent) 2 . To align the objectives of clinicians, patients and providers, a greater emphasis on value is key, and achieving high value care for patients must become the goal of healthcare delivery, thereby reducing costs 3 -5 . Improvements in value can be achieved if resources are reallocated from low-value services towards equally (or more) effective, but less costly, approaches. In the UK, the National Institute for Health and Care Excellence (NICE) commenced a formal agenda in 2006 to address the issue of disinvesting in low-value care/procedure/practice 6 . Initially, a pilot disinvestment programme was introduced, aiming to identify low-value interventions that, if stopped, would save over €1⋅14 million per intervention. However, this was abandoned after NICE concluded that there were few identifiable candidates for total disinvestment, and that NICE's previous strategies (of forming clinical guidance) were already indirectly identifying potential candidates for disinvestment. Consequently, NICE has published recommendation reminders reiterating existing guidance. Furthermore, following the launch of the Department of Health's Quality, Productivity and Prevention programme, NICE reviewed its disinvestment programme and issued 'Do not do' recommendations from their existing guidance 7 . Internationally, the Choosing Wisely movement has also addressed this issue through the promotion of physician and patient conversation, in order to reduce unnecessary interventions. Each specialty was asked to follow the lead taken by the American Board of Internal Medicine by issuing a list of five procedures considered to be of low value, and to reduce their use. The Choosing Wisely campaign has flourished, and has been adopted by other countries including Australia, Germany, Italy, Japan, the Netherlands and Switzerland 8 -10 .
There have been challenges to the Choosing Wisely programme, of note the withdrawal of the American Association of Clinical Endocrinologists, and the limited uptake of issued guidance 11 . Furthermore, surgical societies have selected only low-cost procedures for consideration in the Choosing Wisely campaign 9,11 -16 . The UK recently issued its own Choosing Wisely guidance 17 , with the notable absence of surgical interventions. This appears to be a missed opportunity to improve value, given the financial burden of surgery within health budgets.
An initial step would be to establish a systematic and transparent strategy to identify low-value clinical services for review, with reference to general surgery, the goal being to stimulate discussion, with the objective of reducing low-value care in surgery. The present review focuses on general surgical interventions, and classifies those interventions in terms of potential disinvestment opportunity. A further step was taken to evaluate the impact on the health budget by estimating the monetary value of those low-value interventions.
Methods
A multiplatform method of identifying low-value services was undertaken. This included a peer-reviewed literature search, a targeted database search, and opportunistic sampling. The intention was to identify general surgical procedures or interventions that are currently employed as a result of established practice, or previously published guidance that more recently published research has found to be ineffective, with overestimated or incorrect outcome improvements 18 .
A recognized difficulty with research in the field of disinvestment is the lack of established terminology used to describe low-value procedures 19, 20 . Therefore, an extensive list of keywords was required to perform a comprehensive literature evaluation. The method used presently was similar to that of other published approaches 11 . Previous strategies have yielded such a vast number of articles (159 858 citations) that it was impossible to evaluate every citation and only a fraction of the citations were reviewed (1500 papers). Given this, the present literature review employed strict limitations, gathering the maximum number of relevant papers, in order to accumulate a manageable number of citations that could be evaluated systematically to identify low-value procedures.
Literature review
A MEDLINE search strategy using the PubMed interface was employed, using the keywords and Medical Subject 11 . Filters were applied to identify citations published between 2000 and 2015, publication type (only meta-analyses and systematic reviews were considered), English-language articles, and those with available abstracts. The inclusion of only high-level evidence is due to clinician perspectives that compelling evidence is required for a change in current practice. This had the additional benefit of narrowing the number of citations to a manageable volume 21 . Titles, abstracts and full-text articles were screened according to the previously stated exclusion criteria ( Table 2) .
Targeted database search
All reports from the Cochrane Library were considered, after standard filters (humans, English language, surgery) had been applied. Similarly, all reports from the NICE 'Do not do' recommendations were reviewed. The reason for reviewing these databases is that they both offer valuable sources of high-level evidence that identify areas of current overuse and low-value practices. Therefore, a further 1345 and 1000 citations, respectively, were reviewed using this search method.
Choosing Wisely
All currently published recommendations from the Choosing Wisely movements in the USA, Canada, Japan, Australia and the Netherlands were reviewed. These are based on consensus opinion of established medical literature with the aim of identifying services to stop, and are thus a relevant source of guidance on low-value practices.
Opportunistic sampling
Opportunistic sampling included reports identified by reviewing the full-text article citations; bibliographies of identified key articles were hand-searched for additional relevant articles. A master list of surgical services was compiled following the three search strategies (Appendix S1, supporting information). All citations were assessed to ensure they addressed a clinical general surgical practice or a diagnostic test, and that they had evaluated it against current practice. If no comparison was made, or no clinically relevant outcome was measured and superiority/inferiority demonstrated, the article was excluded, as value of intervention was not determined. Any article concerning novel insights into pathophysiology or a novel molecular basis of disease was excluded. When practice information could not be identified by the abstract alone, the entire article was reviewed. Studies that reported the value of a procedure or service as inferior or similar to current strategies were included.
Further estimation of the impact of each identified low-value intervention was performed by evaluating cost and calculating potential savings. This was done by assessing both the cost of intervention and the incidence per annum in the UK. The frequency of procedure performed was included where available from the Procedures Explorer Tool on the Royal College of Surgeons (RCS) website for the year 2014. This information is derived from the Hospital Episode Statistics (HES) data set, developed through a collaborative project between the RCS Surgical Specialty Associations, NHS England and Right Care 22 . If frequency information was not available through this method, a literature search was performed to identify relevant epidemiology. Frequency information was identified for 36 of the 71 interventions (Appendix S1, supporting information). Interventions for which volume information was not identified included experimental interventions where national data are unavailable (such as use of protease inhibitors, single-incision surgery) or where episodes are not coded for the specific practice (for instance, second-look endoscopy following endoscopic submucosal dissection, choice of expensive gauze dressings). The median frequency (calculated from available data) was 10 058.
Costing information was taken directly from the National Schedule of Reference Costs 2014-2015 23 . Each intervention was costed according to its relevant healthcare resource group (HRG), which is a reimbursement tariff of the average unit cost to the NHS of providing a defined service in a given financial year 24 . Any costs of an intervention beyond the associated HRG, such as the cost of specialized high-cost devices or costs of specific diagnostic imaging per procedure (so-called 'unbundled HRGs'), were not accounted for as they are often not consistently used for a given intervention 24 . Furthermore, assumptions that the interventions were done on outpatients and did not involve any co-morbidities were made in order to make the most conservative estimate possible 23 . It should be noted that this was a crude measure of costing, taking into account only the cost of the intervention as defined by reference costs HRGs, and without performing a formal economic evaluation. Similarly, if costing information was not available through this method, a literature search was performed to identify relevant information. Unit costs were identified for 57 of the 71 interventions (Appendix S1, supporting information). Interventions for which the costs were not identified included those where the cost difference could not be calculated with ease owing to the nature of intervention (such as the cost of extra theatre time for omental wrapping in pancreatic surgery, the use of loop ileostomy in preference to loop colostomy), as well as interventions with a minimal difference between the low-value intervention and the alternative (for example, not using diathermy to prevent surgical-site infection, non-scalpel incision in vasectomy). The median cost (from the available data) was calculated to be €149⋅00.
To categorize the results further, the median cost and frequency were used (€149⋅00 and 10 058 respectively). Thus, all interventions of above-median cost were categorized Final contribution n = 27
Final contribution n = 11
Final contribution n = 7
Records excluded based on title/abstract n = 1326
Records excluded based on title/abstract n = 6658
Final contribution n = 19
Subtotal n = 86
Total n = 71
Duplicates excluded (citations identified from more than one search strategy) n = 15 as high cost. Similarly, interventions that were performed more commonly than the median were categorized into the high-frequency group. Interventions where volume activity information was not available (often due to the intervention being experimental in nature, or not in routine use as against current clinical orthodoxy) were automatically considered low frequency. Ultimately, the interventions were grouped into those with high frequency and high cost (highest impact), low frequency and high cost, high frequency and low cost, and low frequency and low cost (lowest impact).
Results
The search strategy identified 6680 citations, from which 71 low-value services were identified ( Fig. 1 ; Appendix S1, supporting information). The literature review yielded a final contribution of 22 services, with the Cochrane database review identifying 19, the NICE 'Do not do' lists identifying 27 recommendations, the Choosing Wisely published guidance identifying 11 services, and an opportunistic review adding a further seven. After subtracting duplicated low-value services (those identified through more than one search strategy), a final list was compiled.
This list was then further stratified according to impact, by defining the cost per intervention and frequency of use. Five services were in the high-cost, high-frequency group (highest impact); 22 in the high-cost, low-frequency group; 23 in the low-cost, high-frequency group; and 21 in the low-cost, low-frequency group (lowest impact).
Highest impact group
High-frequency and high-cost procedures represent services that place the greatest burden on the current health economy (Table 3) . Traditionally, patients with a hernia are offered surgery to prevent hernia strangulation, which in itself carries a mortality risk. However, the two referenced RCTs 25, 26 highlight the safety of watchful waiting, indicating that the rate of hernia accident is 0⋅11 per cent in patients aged over 65 years 27 . This suggests surgical hernia repair is a low-value procedure. The North American hernia trial's long-term follow-up 27 indicated that there was notable crossover between the two study cohorts, as patients who presented initially with minimal symptoms may have developed worsening symptoms sufficient to warrant intervention. On the other hand, Kaplan-Meier estimates found that after 10 years 32 per cent of patients would still be suitably treated with CT to diagnose appendicitis is performed with excess cost, as it has been demonstrated that alternatives such as ultrasonography and clinical assessment offer improved value. This is particularly true in children, where a CT study in a 5-year-old child has a lifetime risk of radiation-induced cancer of 26⋅1 per 100 000 in girls and 20⋅4 per 100 000 in boys 52, 53 . In 2014 throughout the UK, 32 387 adult and 304 paediatric CT scans were performed for possible appendicitis, accruing potential excess costs of €4 326 627. Euro conversions performed based on exchange rate 28 September 2017.
Traditional treatment of cholecystitis involves antimicrobials for the initial inflammatory response, followed by surgery after an interval. Improved outcomes have been demonstrated with index acute cholecystectomy. Therefore, interval cholecystectomy is low value, with a cost of €1269 per readmission between initial presentation and eventual cholecystectomy 43 . There were 72 572 admissions with right upper quadrant pain, with a 30-day readmission rate of 16⋅75 per cent, amounting to a total cost of €15 436 857. Further, savings of €934 per patient undergoing index cholecystectomy have been estimated 39 . (Caution must be taken here, given the cited study 39 is a German RCT and costs were calculated on the basis of Diagnosis Related Group classification in 2010.) Therefore, with 72 572 non-surgical admissions for right upper quadrant pain, even if 80 per cent of these patients were operated on acutely (a conservative estimate of operative suitability given in the previously cited trial: of 642 patients, only 15 were excluded as unsuitable for acute intervention), €54 251 823 could potentially be saved. Furthermore, it has been demonstrated that the QALYs of laparoscopic cholecystectomy performed within 3 days of admission, beyond 3 days but in the same admission, and electively in a subsequent admission were 0⋅888, 0⋅888 and 0⋅884 respectively over a 1-year horizon, indicating that outcomes are not improved with different treatment strategies 54 .
It is generally accepted that after an episode of acute diverticulitis patients should have endoscopic evaluation to rule out colorectal malignancy. However, recent evidence has called this into question, with de Vries and co-workers' systematic review 46 finding that rates of colonic cancer and advanced adenoma in patients with uncomplicated diverticulitis are equal to, or even less than, the rates encountered in asymptomatic individuals. Therefore, endoscopy following a radiological diagnosis may be considered low value. There were 33 175 patients with an episode of non-operated diverticulitis admitted in the year 2014 in the UK. If each of these patients went on to have outpatient flexible sigmoidoscopy, a cost of €8 392 770 would be incurred.
A meta-analysis 48 from Italy, which examined the appropriateness of referrals for gastroscopy, suggested that 22 per cent were not in line with guidance from the American Society of Gastroenterology, signifying evidence of diagnostic overuse. With 552 078 procedures performed in 2014, this represents a burden of overuse of €40 614 688.
Middle and low impact
Within the high-cost and low-frequency group (Table 4) is the use of early endoscopic retrograde cholangiopancreatography (ERCP) in acute gallstone pancreatitis, which was recommended in the 2005 UK pancreatitis guidelines 66, 67 . However, subsequent evidence, including from a Cochrane review 57 and other meta-analyses 56 , suggests that there may be no benefit to early ERCP in the absence of cholangitis. This is an example of newer evidence changing practice. The incidence of acute pancreatitis is 30 per 100 000, of which 36⋅9 per cent are caused by gallstones 68 . This is a potential 7095 candidates for early ERCP (a low-value procedure), of whom 48 per cent had acute ERCP in 2002 60 ; only a small proportion of these (rate of cholangitis about 4 per cent according to Uy et al. 56 ) would benefit from early ERCP, with potentially 3122 low-value ERCPs being performed and potential savings of €6 398 514.
Further interventions in the high-cost, low-frequency group include those involving new technologies (5 interventions), procedures applied to rare diseases (4 interventions) and procedures not performed commonly owing to alignment with current surgical practice (14 interventions) (Appendix S1, supporting information). Protease inhibitors in ERCP 69 and robotic surgery 58 -64 are examples of new technologies that are seldom used, owing to limited availability. In the case of robotic surgery, there is evidence of moderate improvement in outcomes at a considerable cost, calculated to be €1259 per robotic operation 63, 64 . Literature review also identified different management pathways as being of low value, including the use of second-look gastroscopy after endoscopic mucosal dissection 48 , the benefit of oesophageal stenting before neoadjuvant chemotherapy 70 , and the avoidance of risk-reducing surgery in those with limited life expectancy 71 . These services reflect management pathways that have been instituted following a growing body of evidence and are often not in current practice.
Highlighted high-frequency, low-cost procedures ( Lastly, the group of low-cost, low-frequency procedures ( Table 6 ) includes those that are performed rarely, often with anecdotal evidence justifying current practice.
Discussion
This systematic approach has identified 71 low-value general surgery services. The five with high impact (commonly performed and costly) were: inguinal hernia repair in patients with minimal symptoms, inappropriate gastroscopy, interval cholecystectomy, CT to diagnose appendicitis, and routine endoscopy in those who have had imaging-confirmed diverticulitis. Estimated potential opportunity savings to the NHS of stopping these procedures are €153 383 953 per annum. With five general surgical procedures carrying a burden of €153 million, the Audit Commission's previous estimate 89 (€570 million per annum for all healthcare) is likely to be conservative. Identification and stopping of low-value services represents a significantly greater opportunity for efficiency savings than thought previously. Furthermore, the assessment used conservative assumptions -that all procedures were performed where possible as an outpatient (in the case of endoscopy, ERCP, hernia repair) and in individuals without co-morbidities.
This study also demonstrates the potential opportunity cost of low-value services. For instance, although a high-impact procedure such as index laparoscopic cholecystectomy may offer savings of €67 million per annum, a reduction in the use of mechanical bowel preparation, a low-impact procedure, will confer annual maximum savings of less than €114 000. It is therefore important that clinicians and providers focus debate on the potential reduction of high-impact services.
There are pitfalls with labelling a procedure as low value, as clinical context dictates value 90 . A prime example is inguinal hernia repair in the minimally symptomatic individual. Although the two cited RCTs 25, 26 both found watch-and-wait therapy to be equivalent to surgical repair in the short term, long-term follow-up identified a preference for surgical treatment. Thus, for patients whose symptoms worsened, the procedure would have been of high value. Therefore, an intervention is only low value when applied in the correct clinical context, and stopping these procedures will not be without problems. Complete cessation of elective inguinal hernia repair would result in the reduction of uncomplicated day-case operations with optimal outcomes, to an increase in emergency surgery where further complications such as bowel resection may ensue 25, 26 .
Similarly, stopping CT for the diagnosis of appendicitis may result in incorrect or delayed treatment and subsequently patient harm 28 -38 . Although CT should be considered low value, it may well be that the expertise for accurate ultrasonography, which is heavily operator dependent, is not readily available (particularly out of hours).
Endoscopy following a radiological diagnosis of diverticulitis has been presented as low value here 44 -47 . Yet stopping it may result in missing an early colorectal cancer. Endoscopy should still be considered in patients who have a high risk of colorectal cancer, such as those with a family history.
It is important that stopping low-value interventions happens only in correct clinical populations where the intervention is of little benefit. The challenge lies in identifying patients for whom the clinical context dictates the intervention as low value. Thus, the classical surgical adage of careful patient selection proves true to both economic and surgical objectives.
This study has several limitations. First, the list is not exhaustive, as it focuses solely on high-level evidence (meta-analysis, RCT or systematic review) over a 5-year interval. It is possible that citations that may be relevant have fallen outside the search criteria 91 .
Another challenge is the limitation of the administrative data sets used. For example, when reviewing the use of flexible sigmoidoscopy after CT diagnosis of diverticular disease, or early ERCP in gallstone pancreatitis, although the volume of each procedure was recorded, the indication was not. It is not possible to identify the number of inappropriate procedures performed nationally. Although the number of flexible sigmoidoscopies performed is known, the number of procedures that followed uncomplicated diverticular disease is not. Similarly, the number of early ERCPs performed in gallstone pancreatitis in the absence of cholangitis is unclear. Therefore, assumptions have been made based on potentially outdated literature 92 , or indeed by assuming that surgical orthodoxy will result in all patients with CT-confirmed diverticulitis having flexible sigmoidoscopy. In the case of interval cholecystectomy, costs have been estimated from literature not based in the UK, as the cited study is a German RCT and costs therefore were calculated on the basis of German Diagnosis Related Group classification, using data from 2010 39 . It may be incorrect to extrapolate findings from another country and assume similar rates of non-adherence to guidance in the UK 48 .
Accurately estimating the volume activity of the high-cost, low-frequency procedures has proven difficult. This is often due to the experimental nature of these therapies (for example, robotic and single-incision surgery, protease inhibitor use in ERCP, tetrastarch for fluid resuscitation, and heated carbon dioxide during laparoscopy), as well as the fact that this group deals with disease of rarity. This part of the list often describes procedures that are not performed routinely because current surgical practice is aligned with published guidelines such as avoiding treating varicosities in pregnancy, avoiding routinely offering a defunctioning stoma in operations for anal incontinence, and not offering risk-reducing surgery where there is limited life expectancy. Such services were often found through NICE's 'Do not do' database, highlighting how many of their recommendations are already in line with current practice.
The literature search has highlighted a number of novel technologies, in particular the robotic technique and single-incision approaches. When compared with conventional techniques, outcomes are improved only marginally. Thus, they must be considered low value and a potential candidate for disinvestment. The European Association for Endoscopic Surgery cautions that the benefits of a robotic approach have not been measured, but that it could offer great 'potential with sophisticated electromechanical systems' 58 . There is a global acceptance that robotic surgery is likely to be common in operating theatres of the future, although the costs remain high 93 . This paper should serve as a stimulus for discussion among surgeons, patients and commissioners. It highlights that, in the surgical sphere, there are a number of low-value services that could be stopped, with significant savings.
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